The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
We are at 250p and the CE marking, BAMS and LFT hasn't even been launched.
With 3 weeks left until the end of March Its crazy to think where the SP could get to.
Yes nothing in life is guaranteed but id rather back AVACTA than a long odds on shot at Cheltenham next week - thats for sure.
People saying £10 by the end of year might just be in for a pleasant shock in the next few months imo.
Well done all and best of luck for tomorrow/rest of March.
In Sir AL we trust.
Also in January 2021, Abingdon Health agreed a contract for technical transfer of a UK customer's COVID-19 antigen test into manufacturing and that project commenced in February 2021. The Company welcomed the news from Avacta plc in February 2021 regarding the very encouraging performance data on their COVID-19 antigen test. As a manufacturing partner for Avacta, the Company looks forward to moving their product through technical transfer in due course.
Realistically, and assuming CE mark, BAMS and LFT orders in the next 3-4 weeks, where do people see the SP getting to short term?
Ive topped up again today as personally I think this is still extremely cheap and double figures (if all goes well) is certainly very possible.
All imo - good luck all :)
Apologies if already posted but this was a very interesting read regarding Avactas short and long term potential.
https://alexanderrand.com/invest/avacta-the-next-roche/
Bring on tomorrow morning!
Evening all,
Very well done to all holders. In terms of a future takeover (which seems very likely) what do people see as a realistic SP for this - given that we could easily hit £5-10 in the next few months.
Is £50 a share with a takeover really that farfetched???